US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Inventiva (0RNK) 銘柄情報

Inventiva (0RNK)

7.62

0.00

( 0.00% )

更新日時： 09:00:00

Inventiva (0RNK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

7.62

( - )

買値

7.62

売値

7.62

出来高

70,211

平均取引量 (3 か月)

338,188 €

財務取引量

-

0.00 日の範囲 0.00

7.62 52 週間の範囲 7.62

時価総額

企業価値

939.129M

前日終値

7.62

始値

-

時刻

最終取引時間

23:04:38

VWAP

-

歳入

6.76M

純利益

-354.14M

発行済株式数

236,280,202

浮動株比率 (%)

77.37%

機関投資家保有比率 (%)

71.46%

配当利回り

PER

-1.8

株価売上高倍率 (PSR)

119.52

1 株当たり利益 (EPS)

-1.9

ベータ

0.89

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome prolifer... Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France. 詳細を表示

セクター

-

業界

-

ウェブサイト

inventivapharma.com

本社

Daix, France

設立

2026

Inventiva is listed in the sector of the ロンドン証券取引所 with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 236,280,202 shares in issue. The market capitalisation of Inventiva is 1.80 € billion. Inventiva has a price to earnings ratio (PE ratio) of -1.80.

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026 Daix (France), New York City (New York, United States), July...

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026 Daix (France), New York City (New York, United States...

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt...

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le cadre du Nouveau Financement

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le...

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents Daix (France), New York City (New York, United States), June...

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026 Article R. 22-10-23 of the French Commercial...

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026 Article R. 22-10-23 du Code de...

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires Daix (France), New York City (New York...

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Daix (France), New York City (New York, United...

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Daix (France), New York City (New York, United States), June 2...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	7.62	7.62	7.62	21738	7.62	DE
52	0	0	7.62	7.62	7.62	23659	7.62	DE
156	0	0	7.62	7.62	7.62	7884	7.62	DE
260	0	0	7.62	7.62	7.62	5516	7.62	DE

0RNK - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 7.62 €

How many Inventiva shares are in issue?

Inventiva has 236,280,202 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 1.8B

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 7.62 € to 7.62 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -1.8

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 119.52

What is the registered address of Inventiva?

The registered address for Inventiva is 50 rue de Dijon, Daix, Burgundy, 21121

What is the Inventiva website address?

The website address for Inventiva is inventivapharma.com

2times2

2times2 4分前

Spin-Off! It is a spin off from CGAC. You'll own shares in both companies. SS of CGAC won't change....stratus digital AS would be 100M common to be listed on Nasdaq, and we would get "dividends" in the form of shares. https://www.otcmarkets.com/stock/CGAC/news/PR-2026-April-7-ART-Digital-Holdings-C

Fund_Analyst

Fund_Analyst 4分前

Wound too tight:
I inadvertently forgot to buy FNMA quickly after your previous 93 warnings. Is it now too late for me?

flipper44

flipper44 4分前

Emotion doesn’t disprove a break in trend.

DrHigh

we have no legit investors in this company. Bigger is not credible IMO (look at what he did to SYSX). If I could bet on it i would guess he has traded/shorted NWBO

vlispxpert

vlispxpert 5分前

ORCL a major nibble load imo...we could see all the way down to $123's....it's never filled the $129.84 gap in 2024 and the major gap at $123's double top in 2023...also notice the RSI is not as low as last dip to $134's:

https://schrts.co/kwjsGwvB

I plan on nibbling do

DJPele

The argument stands if you factor in dilution from the company.

DJknows

DJknows 5分前

The following within my last posting is a link that does not work once I've put it up here:

Again, SEMIVISION October 2025 (btw, SemiVision Founder Jett C. is an ardent follower of Lightwave Logic as is FoxConn):
https://substack.com/ @

The above link has receive

KngmAz

Wow - UP - UP and AWAY. Nice.

Drugdoctor

Drugdoctor 6分前

Too bad the smurf is old and tired and broke, as this stock will be easy money for anyone buying shares BEFORE the merger/acquisition NEWS>

bayougirl

bayougirl 6分前

Vivos needs to get the word out somehow! Who is promoting this?

Curt D

ts likely to trigger some of those initial buyers into being sellers
to cut /minimize their losses. Which of course, will fuel further
selling pressure

My average is $166. I personally wouldn't sell and re buy lower. I would add if it dropped way down. As you mentioned,

PennyMillions852

PennyMillions852 7分前

Senseless post yet again by you.....typical!

PennyMillions852

PennyMillions852 7分前

Senseless post yet again by you.....typical!

KevGee59

KevGee59 7分前

BS. It’s an attack beyond the recent trend line which included many dilutions. It’s transparent manipulation. Punishment for sharing very good news. Period.
If anyone believes this, they need to take a serious look at their investing acumen.

JusDePomme

JusDePomme 7分前

One military belt cost around 4000 mxc roughly $260 U.sd x 1600= $416k...it's huge number

dexprs

Oil prices are still moving up. I found that it is not a bad idea to have a couple of oil companies in my portfolio.

BahamaPete

BahamaPete 8分前

TKOI, IMO is flying under the radar, they will update in due time. Huge confidence in Gewiss!

Got $TKOI ???

The Truth Hurts

The Truth Hurts 8分前

Might be an opportunity with new ownership, small SS, and now cleared off debt.

Its_TradingG

Its_TradingG 8分前

This economy under $DJT stinks, no wins for the regular investor!!

tundra1

tundra1 8分前

True, you are good with the words, when are we going to see revenues from your promotional(S)??

flipper44

flipper44 9分前

I’m very disappointed with management communication regarding progress, but very upset with external suppression.

dexprs

Never mess with Kangaroos, they have a powerful kick, I learned when I was in Australia.

Mr Stock pick

Mr Stock pick 9分前

No Henk we are beyond the “Nothing” phase but agree with what you said about the die hard lightwaivians

Best to the longs

Johnnycombat10

Johnnycombat10 9分前

I will wait for the next filing to be made. Then I will have more information to make a better judgment.

SembCorp Industries

Rea Fin 8.75%25

Khiron Life Sciences (EM)

Exchange Traded

Leverage Shares 5x Short...

Algoma Cent (PK)

Euronext CDP Environment...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。